Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study Effect of WHO Recommended Dose of Pralidoxime in the Treatment of Organophosphorus Poisoning

NCT02040350 is registered in ClinicalTrials.gov with Sheri Kashmir Institute of Medical Sciences as lead sponsor.

NCT NCT02040350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02040350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study Effect of WHO Recommended Dose of Pralidoxime in the Treatment of Organophosphorus Poisoning
Lead sponsor
Sheri Kashmir Institute of Medical Sciences
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2012
Completion date
November 30, 2013
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

deaths